Recently, the US National Academy of Sciences (PNAS) published the latest project progress of a group of Israeli scientists. They prepared several kinds of anti-HER3 monoclonal antibodies. By comparing their ability inRead More…
As there is great competitiveness in the field of new drug research and development, how can these young researchers stand out of the great number of candidates? In addition to master the mostRead More…
Bio-pharmaceutical industry is now in its infancy. We are in urgent need of a great number of researchers with professional knowledge and technical skills in diseases to join the industry and engageRead More…
Creative Biolabs is gladly to show a series of De Novo Antibody Sequencing services, which were developed based on its next generation antibody sequencing platform with the “Database Assisted Shotgun Sequencing” (DASS) technology. AllRead More…
CAR-T (T cell chimeric antigen receptor), as an immune cell therapy has attracted worldwide attention including academics, doctors, patients and investors. However, what’s CAR-T exactly? What’s the background of it? What’s theRead More…
With the development of science, traditional Sanger sequencing has failed to meet new requirements of low cost, high throughput and fast in speed. Under such a circumstance, the next-generation sequencing technology (second-generationRead More…
Karolinska Institute in Stockholm awarded the 2015 Nobel Prize in Physiology or Medicine jointly with one half to Chinese female pharmacist Youyou Tu and the other half to William C. Campbell andRead More…
It is reported that some researchers from KCL have found a new gene named MX2, which can restrain the spread of AIDS virus to a large degree. Those researchers said the discoveryRead More…
Since a long time, the fact that gene mutation can cause abnormal growth of cells has been considered as the source of cancer. However, in recent days, some reports indicate that residualRead More…
Recently, some scientists have raised a idea that scFv shouldn’t focus on the traditional antibody because modern new drugs require more efficient antibodies. The latest research progress in scFv has indicated thereRead More…